arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

InflaRx N.V.

IFRX Health Care Biotechnology: Pharmaceutical Preparations
$1.65
▼ -6.8% Today
as of Aug 5, 16:50 ET
Last 30 days -22.37% Jun 29 → Aug 05
$1.60 $1.79 $1.99 $2.19 $2.38 Jun 29 Jul 07 Jul 14 Jul 22 Jul 29 Aug 05
Open
$1.99
High
$1.99
Low
$1.81
Volume
$1M
Avg Vol
$1M
Mkt Cap
$127M
P/E (TTM)
—
Beta
—
52w High
$2.95
52w Low
$0.74
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 3 items

Jul 30 · 11:30 PR GlobeNewswire
InflaRx to Report Second Quarter 2026 Results on August 6, 2026
Jun 30 · 11:30 PR GlobeNewswire
InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos
Jun 10 · 18:22 Insider Monkey
What Do Analysts Say About InflaRx N.V. (IFRX)?

Overview

52-week range
$0.74
$2.95
41% of range
Avg surprise (last 3)
+23.1%
Avg reaction (last 2)
+9.7%
50% positive
Latest IV / EM
372%
EM ±62.1% · $2 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.24$-0.20$-0.16$-0.13$-0.09 Actual $-0.14Est $-0.18Actual $-0.24Est $-0.24Actual $-0.09Est $-0.17 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-0.09 $-0.17 +47.1% +35.7% +26.9% earnings
Thu Aug 7, 2025Jun/2025 $-0.24 $-0.24 0.0% — — earnings
Wed May 7, 2025Mar/2025 $-0.14 $-0.18 +22.2% — -7.5% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Thu Aug 6, 2026Jun/2026BMO -$0.08-$0.24 +66.7%

Implied volatility — last 90 days

64%169%275%380%485% Jun 08 — IV 465% · EM ±61.4%Jun 09 — IV 486% · EM ±60.8%Jun 19 — IV 138% · EM ±30.4%Jun 22 — IV 146% · EM ±30.4%Jun 23 — IV 266% · EM ±54.4%Jun 24 — IV 65% · EM ±13.0%Jun 25 — IV 66% · EM ±13.0%Jun 30 — IV 233% · EM ±40.2%Jul 01 — IV 141% · EM ±23.6%Jul 02 — IV 146% · EM ±23.6%Jul 10 — IV 450% · EM ±49.8%Jul 13 — IV 407% · EM ±34.0%Jul 14 — IV 470% · EM ±34.0%Jul 20 — IV 105% · EM ±24.7%Jul 21 — IV 113% · EM ±26.2%Jul 22 — IV 86% · EM ±19.8%Jul 23 — IV 283% · EM ±63.6%Jul 27 — IV 310% · EM ±64.7%Aug 04 — IV 277% · EM ±47.8%Aug 05 — IV 372% · EM ±62.1%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in